UBS downgraded Crane to Neutral from Buy with a price target of $120, down from $132. The analyst thinks Crane’s path to unlocking further shareholder value is "likely bumpier and slower in the near term." The firm sees a risk of "relatively subdued early standalone valuation" for NXT due to lack of clear comps and target investors, which could potentially bring a more attractive entry point post separation. UBS thinks a further multiple re-rating of Crane shares will largely hinge on future acquisition execution at both companies, as well as evidence of sustained outgrowth and margin improvement.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CR: